NB32

More Obesity Drugs Seek to Enter Still Struggling Market
Bloomberg
Tue, 09/9/14 - 08:08 am
obesity
Orexigen
Novo Nordisk
NB32
liraglutide
Victoza
Takeda
The Implications of Obesity as a Disability in Europe
Motley Fool
Sun, 07/20/14 - 09:10 am
obesity
weight loss
Arena Pharmaceuticals
Belviq
Orexigen
Vivus
Eisai
Qsymia
NB32